Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line

6 Apr 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Protein Kinase Regulation and GTPase Signaling
Share to Ubiquitin and proteasome pathways

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 21458422
DOI: 10.1016/j.bcp.2011.03.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell linePMID 21458422Read ↗

Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical ApplicationsSemantic proximity Read ↗

Bryostatin-I—An Antineoplastic Treasure from the Deep?Semantic proximity Read ↗

Atractylenolide I ameliorated the progression of CRPC by suppressing KIF15/AR/AR-V7 signalingSemantic proximity Read ↗

Bryostatin-1, a naturally occurring antineoplastic agent, acts as a Toll-like receptor 4 (TLR-4) ligand and induces unique cytokines and chemokines in dendritic cells.Semantic proximity Read ↗

Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancerSemantic proximity Read ↗

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapySemantic proximity Read ↗

Dissecting the role of microRNAs in the radiation response of human prostate cancerSemantic proximity Read ↗

Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.Semantic proximity Read ↗

Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapySemantic proximity Read ↗

Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.Semantic proximity Read ↗

Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19Semantic proximity Read ↗

A Glutamine antagonist-modulated tumor microenvironment unleashes enzalutamide’s immunotherapeutic effectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.